2022
COVID-19 Vaccine Hesitancy Among Medicare Beneficiaries with and Without Cancer History: A US Population-based Study
Poghosyan H, Ni Z, Vlahov D, Nelson L, Nam S. COVID-19 Vaccine Hesitancy Among Medicare Beneficiaries with and Without Cancer History: A US Population-based Study. Journal Of Community Health 2022, 48: 315-324. PMID: 36427111, PMCID: PMC9702715, DOI: 10.1007/s10900-022-01174-5.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccineCOVID-19 vaccine hesitancyCancer historyVaccine hesitancyMedicare beneficiariesVaccine uptakeMultivariable logistic regression modelCOVID-19 vaccine uptakeVaccine hesitancy ratesOngoing health conditionsCOVID-19 vaccinationLogistic regression modelsComplex survey designLack of recommendationsHesitancy ratesVaccine benefitsCommon reasonHesitant individualsSide effectsUS populationVaccineHealth conditionsCross-sectional dataHesitancyRegression models
2000
Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals
Kuo I, Fischer B, Vlahov D. Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals. International Journal Of Drug Policy 2000, 11: 357-370. PMID: 10967518, DOI: 10.1016/s0955-3959(00)00057-8.Peer-Reviewed Original ResearchMethadone treatmentMajor public health problemOpiate addictsAdditional treatment strategiesHeroin-assisted treatmentPrincipal treatment modalityPublic health problemOpiate-dependent individualsSubstance abuse treatmentTreatment modalitiesClinical trialsTreatment outcomesTreatment strategiesSide effectsEconomic burdenHealth problemsInjectable opiatesTreatment programAbuse treatmentTreatment participationEffective interventionsTreatmentPositive resultsAddictsRecent studies